Back
Kiniksa Pharmaceuticals International PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
58
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
25.01
Seasonality Move:
17.99%
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
Buy
58
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $25.00. The Score for KNSA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals International PLC's stock price today?
-
The Kiniksa Pharmaceuticals International PLC share price today is $25.00
The current trend is relatively stagnant and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
KNSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 49.67 | Sell |
Chaikin Money Flow: | 408914 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.38 - 26.5) | Sell |
Bollinger Bands (100): | (19.3 - 25.58) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.58 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | 227264 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (257.28 - 277.8) | Buy |
Bollinger Bands (100): | (173.47 - 275.75) | Buy |
KNSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.92 | Buy |
20-day SMA: | 25.05 | Sell |
50-day SMA: | 25.38 | Sell |
200-day SMA: | 20.7 | Buy |
8-day EMA: | 24.74 | Buy |
20-day EMA: | 25.03 | Sell |
50-day EMA: | 24.53 | Buy |
200-day EMA: | 21.14 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 273.53 | Buy |
20-day SMA: | 264.94 | Buy |
50-day SMA: | 262.48 | Buy |
200-day SMA: | 194.67 | Buy |
8-day EMA: | 272.54 | Buy |
20-day EMA: | 269.21 | Buy |
50-day EMA: | 257.72 | Buy |
200-day EMA: | 211.82 | Buy |
Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.04 per share, an increase this year of $0.40 per share, and an increase next year of $0.81 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Kiniksa Pharmaceuticals International PLC Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |